In contrast to the tumor-promoting function of IL-22 discussed above, NLRP3/IL-18-mediated downregulation of IL-22BP under controlled production can also provide protective roles against intestinal tissue damage during the inflammation peak (42). The gene discussed is NLRP3; the disease is neoplasm.